Literature DB >> 4562008

Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.

R L Simmons, A Rios.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4562008      PMCID: PMC1355302          DOI: 10.1097/00000658-197208000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  25 in total

1.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

2.  Effect of neuraminidase on the phagocytosis of heterologous red cells by mouse peritoneal macrophages.

Authors:  A Lee
Journal:  Proc Soc Exp Biol Med       Date:  1968-07

3.  Immunogenicity of L 1210 murine leukaemia cells after treatment with neuraminidase.

Authors:  K D Bagshawe; G A Currie
Journal:  Nature       Date:  1968-06-29       Impact factor: 49.962

4.  Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

Authors:  D L Morton; F R Eilber; W L Joseph; W C Wood; E Trahan; A S Ketcham
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

5.  The effect of neuraminidase on the phagocytic process in human monocytes.

Authors:  L Weiss; E Mayhew; K Ulrich
Journal:  Lab Invest       Date:  1966-08       Impact factor: 5.662

6.  Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.

Authors:  B Zbar; T Tanaka
Journal:  Science       Date:  1971-04-16       Impact factor: 47.728

7.  Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.

Authors:  G A Currie; K D Bagshawe
Journal:  Br J Cancer       Date:  1969-03       Impact factor: 7.640

8.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

9.  The effect of neuraminidase on the fate of transfused lymphocytes.

Authors:  J J Woodruff; B M Gesner
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

10.  The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour.

Authors:  G A Currie; K D Bagshawe
Journal:  Br J Cancer       Date:  1968-12       Impact factor: 7.640

View more
  2 in total

1.  Antitumor immune response following injection of neuraminidase-treated sarcoma cells.

Authors:  R P Faraci; J A Marrone; A S Ketcham
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

Review 2.  Immunology of bronchial carcinoma.

Authors:  D A Evans
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.